Stimulants drugs increase the activity of the central nervous system producing feelings of euphoria, increased confidence, sociability, energy, and wakefulness.
Pharmacotherapy for Methamphetamine/Amphetamine Use Disorder — A Systematic Review and Meta-Analysis
This meta-analysis of research on medication to treat methamphetamine use disorder finds that only one medication, methylphenidate, has any efficacy in reducing use.
To assist workplaces to respond to alcohol and other drug-related harm in the workplace, The National Centre for Education and Training on Addiction, has produced a series of factsheets about commonly used drugs and their impact on safety and well-being of individual employees, and overall safety and productivity of the workplace.
Fact sheets cover the following topics:
Evaluation of Amphetamine-Related Hospitalizations and Associated Clinical Outcomes and Costs in the United States
Question: What are the current trends in frequency and costs of amphetamine-related hospitalizations in the United States?
This review provides an up‐to‐date curated source of information on alcohol, tobacco and illicit drug use and their associated mortality and burden of disease. Limitations in the data are also discussed, including how these can be addressed in the future.
Rewarding people dependent on illegal drugs for not using those drugs is a controversial tactic, one this report from the European Union’s drug misuse centre found patchily effective in extending retention and reducing substance use as a supplement to medication-based treatments. Read the Effectiveness Bank analysis.
As part of an increasing worldwide use of designer drugs, recent use of compounds containing cathinones and synthetic cannabinoids is especially prevalent. Here, we reviewed current literature on the prevalence, epidemiology, bio-behavioral effects, and detection of these compounds. Gender differences and clinical effects will also be examined.